275 related articles for article (PubMed ID: 27246751)
1. Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma.
Frommelt P; Juern A; Siegel D; Holland K; Seefeldt M; Yu J; Uhing M; Wade K; Drolet B
Pediatr Dermatol; 2016 Jul; 33(4):405-14. PubMed ID: 27246751
[TBL] [Abstract][Full Text] [Related]
2. Topical timolol for small hemangiomas of infancy.
Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
[TBL] [Abstract][Full Text] [Related]
3. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
[TBL] [Abstract][Full Text] [Related]
4. β-blockers for infantile hemangiomas: a single-institution experience.
Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
[TBL] [Abstract][Full Text] [Related]
5. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
[TBL] [Abstract][Full Text] [Related]
6. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
Ge J; Zheng J; Zhang L; Yuan W; Zhao H
Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
[TBL] [Abstract][Full Text] [Related]
7. Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption.
Weibel L; Barysch MJ; Scheer HS; Königs I; Neuhaus K; Schiestl C; Rentsch K; Müller DM; Theiler M
Pediatr Dermatol; 2016; 33(2):184-90. PubMed ID: 26840644
[TBL] [Abstract][Full Text] [Related]
8. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
Chan H; McKay C; Adams S; Wargon O
Pediatrics; 2013 Jun; 131(6):e1739-47. PubMed ID: 23650294
[TBL] [Abstract][Full Text] [Related]
9. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
10. The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis.
Khan M; Boyce A; Prieto-Merino D; Svensson Å; Wedgeworth E; Flohr C
Acta Derm Venereol; 2017 Nov; 97(10):1167-1171. PubMed ID: 28421234
[TBL] [Abstract][Full Text] [Related]
11. Topical timolol gel for infantile hemangiomas: a pilot study.
Pope E; Chakkittakandiyil A
Arch Dermatol; 2010 May; 146(5):564-5. PubMed ID: 20479314
[No Abstract] [Full Text] [Related]
12. Current concepts in the management of periocular infantile (capillary) hemangioma.
Ni N; Guo S; Langer P
Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
Liu LS; Sokoloff D; Antaya RJ
Pediatr Dermatol; 2013; 30(5):554-60. PubMed ID: 23829941
[TBL] [Abstract][Full Text] [Related]
14. Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection.
Zhang JY; Lan SJ; Liu M; Yang TY; Liu SS; Rong L
J Craniofac Surg; 2021 May; 32(3):988-990. PubMed ID: 33538448
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies.
Huang H; Chen X; Cai B; Yu J; Wang B
Dermatol Ther; 2022 Dec; 35(12):e15907. PubMed ID: 36205218
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
[TBL] [Abstract][Full Text] [Related]
17. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
[TBL] [Abstract][Full Text] [Related]
18. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
[TBL] [Abstract][Full Text] [Related]
20. Episcleral infantile hemangioma successfully treated with topical timolol.
Ciudad Blanco C; Campos Domínguez M; Moreno García B; Villanueva Álvarez-Santullano CA; Berenguer Fröhner B; Suárez Fernández R
Dermatol Ther; 2015; 28(1):22-4. PubMed ID: 25286087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
